PH12012500850A1 - Methods for diagnosing irritable bowel syndrome - Google Patents

Methods for diagnosing irritable bowel syndrome

Info

Publication number
PH12012500850A1
PH12012500850A1 PH1/2012/500850A PH12012500850A PH12012500850A1 PH 12012500850 A1 PH12012500850 A1 PH 12012500850A1 PH 12012500850 A PH12012500850 A PH 12012500850A PH 12012500850 A1 PH12012500850 A1 PH 12012500850A1
Authority
PH
Philippines
Prior art keywords
methods
bowel syndrome
irritable bowel
diagnosing
diagnosing irritable
Prior art date
Application number
PH1/2012/500850A
Other languages
English (en)
Inventor
Hua Gong
Sharat Singh
Shui Long Wang
Original Assignee
Prometheus Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometheus Laboratories Inc filed Critical Prometheus Laboratories Inc
Publication of PH12012500850A1 publication Critical patent/PH12012500850A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PH1/2012/500850A 2009-10-30 2010-10-29 Methods for diagnosing irritable bowel syndrome PH12012500850A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25671709P 2009-10-30 2009-10-30
US26458809P 2009-11-25 2009-11-25
US32617610P 2010-04-20 2010-04-20
PCT/US2010/054810 WO2011053831A1 (en) 2009-10-30 2010-10-29 Methods for diagnosing irritable bowel syndrome

Publications (1)

Publication Number Publication Date
PH12012500850A1 true PH12012500850A1 (en) 2013-01-07

Family

ID=43922588

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/500850A PH12012500850A1 (en) 2009-10-30 2010-10-29 Methods for diagnosing irritable bowel syndrome

Country Status (14)

Country Link
US (1) US20120315630A1 (enExample)
EP (1) EP2494074A4 (enExample)
JP (1) JP2013509593A (enExample)
KR (1) KR20120101038A (enExample)
CN (1) CN102712956A (enExample)
AU (1) AU2010313292A1 (enExample)
BR (1) BR112012010108A2 (enExample)
CA (1) CA2778539A1 (enExample)
IL (1) IL219317A0 (enExample)
MX (1) MX2012005015A (enExample)
PH (1) PH12012500850A1 (enExample)
RU (1) RU2012122180A (enExample)
WO (1) WO2011053831A1 (enExample)
ZA (1) ZA201203718B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857503B2 (ja) * 2010-07-29 2016-02-10 小野薬品工業株式会社 ストレス性疾患のバイオマーカー
WO2012158831A1 (en) 2011-05-16 2012-11-22 Prometheus Laboratories Inc. Performance of a biomarker panel for irritable bowel syndrome
NZ702643A (en) * 2012-05-19 2016-06-24 Falk Pharma Gmbh Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate
AU2013326133B2 (en) * 2012-10-05 2019-07-04 Société des Produits Nestlé S.A. Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for IBS
WO2014082034A1 (en) * 2012-11-26 2014-05-30 Lexicon Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome
CN103175971B (zh) * 2013-02-28 2016-10-05 苏州和锐医药科技有限公司 一种IgA抗体检测试剂盒
EP3800470A1 (en) * 2013-03-15 2021-04-07 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
RU2015155552A (ru) * 2013-05-24 2017-06-27 Нестек С.А. Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника
CA2930330A1 (en) * 2013-12-27 2015-07-02 Dignity Health Diagnosing and treating alzheimer's disease
JP6713723B2 (ja) * 2014-02-18 2020-06-24 小野薬品工業株式会社 過敏性腸症候群の診断用バイオマーカー
US10392665B2 (en) 2015-06-19 2019-08-27 Sera Prognostics, Inc. Biomarker pairs for predicting preterm birth
CN106446599A (zh) * 2015-08-11 2017-02-22 中国科学院青岛生物能源与过程研究所 一种筛选婴幼儿龋病的口腔致病性生物标记物的方法
CN105687225B (zh) * 2016-02-26 2018-07-06 四川好医生攀西药业有限责任公司 一种治疗肠易激综合征的药物组合物及其制备方法和应用
GB201605110D0 (en) * 2016-03-24 2016-05-11 Mologic Ltd Detecting sepsis
US10817778B2 (en) 2016-06-27 2020-10-27 International Business Machines Corporation Customized cooking utilizing deep learning neuromorphic computing of hyperspectral input
AU2017325986B2 (en) * 2016-09-16 2023-12-14 Takeda Pharmaceutical Company Limited Metabolite biomarkers for diseases associated with the contact activation system
RU2668496C2 (ru) * 2017-03-16 2018-10-01 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Способ диагностики тяжести течения синдрома раздраженного кишечника
CN106990057A (zh) * 2017-05-05 2017-07-28 贵州普洛迈德生物工程有限公司 一种检测5‑羟吲哚乙酸试剂及制备方法
US11662351B2 (en) 2017-08-18 2023-05-30 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
US11488699B1 (en) 2018-12-09 2022-11-01 Cerner Innovation, Inc. Microbiota activity sensor and decision support tool
US11842795B1 (en) * 2018-12-17 2023-12-12 Cerner Innovation, Inc. Irritable bowel syndrome diagnostic sensor and decision support tool
KR102330639B1 (ko) * 2019-01-18 2021-11-24 주식회사 천랩 과민성대장증후군 특이적 미생물 바이오마커와 이를 이용하여 과민성대장증후군의 위험도를 예측하는 방법
US20220146527A1 (en) * 2019-09-17 2022-05-12 Chang Gung University Method of creating characteristic profiles of mass spectra and identification model for analyzing and identifying features of microorganisms
US20240124524A1 (en) * 2019-10-17 2024-04-18 University Of Copenhagen Agonist of Tacr2
CN112921100A (zh) * 2019-12-06 2021-06-08 宁波海尔施基因科技有限公司 一种检测人类压力敏感度基因型的试剂盒和方法
EP3913371A1 (en) * 2020-05-18 2021-11-24 Neuroimmun GmbH Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions
CN111784683B (zh) * 2020-07-10 2022-05-17 天津大学 病理切片检测方法及装置、计算机设备及存储介质
CN111905111B (zh) * 2020-09-16 2023-03-31 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
US20220208375A1 (en) * 2020-12-29 2022-06-30 Kpn Innovations, Llc. System and method for generating a digestive disease functional program
CN115328117B (zh) * 2022-07-15 2023-07-14 大理大学 基于强化学习的蛋白质动态配体通道最优路径分析方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057120A1 (en) * 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
EP1315837A2 (en) * 2000-09-06 2003-06-04 Glaxo Group Limited 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
EP2778685B1 (en) * 2009-06-25 2017-04-26 Nestec S.A. Methods for diagnosing irritable bowel syndrome

Also Published As

Publication number Publication date
US20120315630A1 (en) 2012-12-13
ZA201203718B (en) 2014-11-26
RU2012122180A (ru) 2013-12-10
MX2012005015A (es) 2012-06-12
IL219317A0 (en) 2012-06-28
CN102712956A (zh) 2012-10-03
JP2013509593A (ja) 2013-03-14
CA2778539A1 (en) 2011-05-05
AU2010313292A1 (en) 2012-06-07
EP2494074A4 (en) 2013-06-12
KR20120101038A (ko) 2012-09-12
BR112012010108A2 (pt) 2016-05-31
WO2011053831A1 (en) 2011-05-05
EP2494074A1 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
PH12012500850A1 (en) Methods for diagnosing irritable bowel syndrome
PH12012501016A1 (en) Novel genomic biomarkers for irritable bowel syndrome diagnosis
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
WO2011035012A3 (en) Methods and compositions for diagnosing heart failure
WO2009115615A3 (en) Detection and prognosis of cervical cancer
WO2011106746A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1223361A1 (zh) 用於预测肠易激综合征诊断的途径特异性测定
EP2558597A4 (en) EARLY DETECTION AND STADIFICATION OF COLORECTAL CANCER USING A MICRO-RNA PANEL
EP2767833A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2019015159A (es) Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica.
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
MX340453B (es) Biomarcadores para cancer de pulmon.
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
EA201290629A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
HK1259001A1 (zh) 癌症的预後和诊断方法
EP2585827A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
WO2010115745A3 (en) Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
HK1231555A1 (zh) 生物标志物及其用途
WO2012168448A3 (en) Complex sets of mirnas as non-invasive biomarkers for dilated cardiomyopathy
MX2014000283A (es) Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.
WO2012085574A3 (en) Detection of acute myeloid leukaemia
WO2011130647A3 (en) Compositions and methods for characterizing a myopathy